Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Journal of Proteome Research|May 26, 2007
Quantitation of multisite EGF receptor phosphorylation using mass spectrometry and a novel normalization approachElisabetta Boeri Erba, Rune Matthiesen, Jakob Bunkenborg, et al.
Oncotarget|September 27, 2017
Cooperative but distinct early co-signaling events originate from ERBB2 and ERBB1 receptors upon trastuzumab treatment in breast cancer cellsPaola Bagnato, Alessia Castagnino, Katia Cortese, et al.
Plos One|December 15, 2012
p130Cas over-expression impairs mammary branching morphogenesis in response to estrogen and EGFMaria del Pilar Camacho Leal, Alessandra Pincini, Giusy Tornillo, et al.
Frontiers in Oncology|June 2, 2023
The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneityVincenzo Salemme, Giorgia Centonze, Lidia Avalle, et al.
European Journal of Cell Biology|October 22, 2010
p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1Giusy Tornillo, Brigitte Bisaro, Maria del Pilar Camacho-Leal, et al.
The Journal of Biological Chemistry|September 1, 2025
A biophysical and molecular characterization of the interaction between the Alzheimer risk factor BIN1 and the neuronal scaffold protein p140CapDanielle M Blazier, Eric M Lewandowski, Natasha Ram, et al.
Blood|June 17, 2004
Nongenomic effects of 17beta-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinaseLaura Moro, Stefania Reineri, Daniela Piranda, et al.
Journal of Cell Science|March 17, 2004
p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cellsSara Cabodi, Laura Moro, Germano Baj, et al.
Scientific Reports|March 1, 2019
Modeling ErbB2-p130Cas interaction to design new potential anticancer agentsAndrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini, et al.
Scientific Reports|November 24, 2019
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agentsAndrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini, et al.
Pageof 9